Let’s deal in facts.
EDE is not yet a high-margin, large-scale revenue business. It’s in the commercialisation phase. Revenue exists, but scale is still developing. That’s a fair observation.
But the share price did not move in a vacuum.The last meaningful run occurred on identifiable catalysts: 1) The CRRI trials in India — a potentially material validation event in one of the world’s largest infrastructure markets. 2) The announced sale of company properties — strengthening the balance sheet and reducing overhang concerns. 3) Ongoing support from 7 Enterprises — signaling aligned backing rather than abandonment.
Those are tangible developments.
Markets price forward expectation, not trailing income statements. In small caps, anticipation of validation and balance sheet improvement can legitimately drive re-ratings before revenue fully reflects the opportunity.
As for price being “pushed” — this is a microcap. When liquidity is light, relatively modest capital can move the tape quickly. That’s structure, not conspiracy. Buyers step up, price moves. Sellers emerge, price retraces. That’s order flow.
The real question is whether the CRRI process converts to commercial adoption, whether the balance sheet continues to strengthen, and whether revenue inflects from here. If those catalysts convert, the move will look rational in hindsight.
Let’s deal in facts.EDE is not yet a high-margin, large-scale...
Add to My Watchlist
What is My Watchlist?